Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVID
1726
DELISTED
Avid Technology Inc
AVID
| $3.69M | ﹤0.01% |
115,267
+17,582
| +18% | +$520K |
|
1727
Donaldson
DCI
$10.9B
| $3.68M | ﹤0.01% |
56,370
+1,851
| +3% | +$116K |
|
|
EVA
1728
DELISTED
Enviva Inc.
EVA
| $3.68M | ﹤0.01% |
127,307
+77,865
| +157% | +$3.18M |
|
1729
Ultragenyx Pharmaceutical
RARE
$2.45B
| $3.68M | ﹤0.01% |
91,667
-32,920
| -26% | -$1.41M |
|
1730
Noble Corp
NE
$6.77B
| $3.67M | ﹤0.01% |
93,049
+64,777
| +229% | +$2.59M |
|
|
LSXMA
1731
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $3.66M | ﹤0.01% |
177,574
+85,614
| +93% | +$2.15M |
|
1732
PUT
Atlassian
TEAM
$25.6B
| $3.66M | ﹤0.01% |
21,400
+1,400
| +7% | +$223K |
|
1733
Ormat Technologies
ORA
$6B
| $3.66M | ﹤0.01% |
43,198
+17,001
| +65% | +$1.49M |
|
1734
Mercury Systems
MRCY
$5.83B
| $3.64M | ﹤0.01% |
71,238
+62,973
| +762% | +$3.18M |
|
1735
Performance Food Group
PFGC
$18B
| $3.64M | ﹤0.01% |
60,319
-7,326
| -11% | -$428K |
|
1736
Visteon
VC
$2.79B
| $3.64M | ﹤0.01% |
23,183
+5,609
| +32% | +$868K |
|
|
EFOR
1737
Everforth Inc
EFOR
$1.17B
| $3.63M | ﹤0.01% |
43,965
+4,293
| +11% | +$372K |
|
1738
Popular Inc
BPOP
$11.2B
| $3.63M | ﹤0.01% |
63,194
-1,460
| -2% | -$95.1K |
|
1739
NCR Voyix
VYX
$1.14B
| $3.62M | ﹤0.01% |
250,185
+44,991
| +22% | +$691K |
|
1740
Worthington Enterprises
WOR
$2.75B
| $3.62M | ﹤0.01% |
90,819
+28,818
| +46% | +$1.02M |
|
|
CFFS
1741
DELISTED
CF Acquisition Corp. VII Class A Common Stock
CFFS
| $3.62M | ﹤0.01% |
350,000
| – | – |
|
|
TRIS
1742
DELISTED
Tristar Acquisition I Corp.
TRIS
| $3.62M | ﹤0.01% |
350,000
| – | – |
|
1743
Perion Network
PERI
$375M
| $3.6M | ﹤0.01% |
90,946
+33,415
| +58% | +$1.11M |
|
1744
Brookfield Infrastructure
BIPC
$5.2B
| $3.59M | ﹤0.01% |
77,942
+25,272
| +48% | +$1.1M |
|
1745
Huntsman Corp
HUN
$1.71B
| $3.58M | ﹤0.01% |
131,030
-125,897
| -49% | -$3.75M |
|
1746
DXC Technology
DXC
$1.82B
| $3.58M | ﹤0.01% |
139,940
-639,580
| -82% | -$17.4M |
|
1747
Kinross Gold
KGC
$27.4B
| $3.57M | ﹤0.01% |
758,701
-69,597,698
| -99% | -$295M |
|
1748
Guardant Health
GH
$21.7B
| $3.57M | ﹤0.01% |
152,444
+8,112
| +6% | +$232K |
|
1749
Greif
GEF
$4.92B
| $3.57M | ﹤0.01% |
56,379
+6,436
| +13% | +$431K |
|
|
CHX
1750
DELISTED
ChampionX
CHX
| $3.54M | ﹤0.01% |
130,628
+56,700
| +77% | +$1.69M |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.